BAY-1816032
目录号: A19868
BUB1 kinase inhibitor
BAY-1816032 是一种有效的口服 BUB1 (budding uninhibited by benzimidazoles 1) 激酶抑制剂,其 IC50 为 7 nM。
Discription | BAY-1816032 is a potent and oral available BUB1 (budding uninhibited by benzimidazoles 1) kinase inhibitor with an IC50 of 7 nM. |
---|
目录号 | A19868 |
---|---|
分子式 | C27H24F2N6O4 |
分子量 | 534.51 |
CAS号 | 1891087-61-8 |
SMILES | COC1=C(NC2=NC(C3=NN(CC4=C(F)C=C(OCCO)C=C4F)C5=C3C=CC=C5)=NC=C2OC)C=CN=C1 |
其他名称 | BAY1816032, BAY 1816032 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 47 mg/mL (87.93 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.71 mL | 93.54 mL | 187.09 mL |
0.5 mM | 3.74 mL | 18.71 mL | 37.42 mL |
1 mM | 1.87 mL | 9.35 mL | 18.71 mL |
5 mM | 0.37 mL | 1.87 mL | 3.74 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2